Replimune (REPL) shares slipped in the premarket on Friday after the company announced that the FDA will convene an advisory committee to review its lead drug, RP1, following the regulator's ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

The Genographic Project began in 2005 and is a research project carried out by the National Geographic Society’s scientific team to reveal patterns of human migration. The project is carried out in ...